Culmination Bio

Home - Intermountain Health

United States · Founded 2022 · $10.0M raised

Headquarters
Utah
Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$10.0M
Last Round
$10.0M SeedNov 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Culmination Bio is a biotech company spun out of Intermountain Health that builds an anonymized, de-identified patient-data intelligence platform combining omics-level and real-world clinical data to generate novel diagnostic and therapeutic insights. Led by CEO Lincoln Nadauld, the company launched publicly in March 2023 with backing from Intermountain Ventures and has since formed data and research partnerships with Merck, Amgen, and BillionToOne to advance precision medicine and oncology diagnostics.

Summary

Culmination Bio is a Biotech company based in United States, founded in 2022. It has raised $10.0M in total across 1 round, most recently a $10.0M Seed round in Nov 2023. Investors include Amgen and Merck Global Health Innovation Fund.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundNov 2023
$10.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Culmination Bio on Indexed.vc
<a href="https://indexed.vc/companies/culmination-bio"><img src="https://indexed.vc/api/badge/company/culmination-bio" alt="Culmination Bio on Indexed.vc" width="260" height="76" /></a>